Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents

ACS Nano

Volumn 8, Issue 5, 2014, Pages 5049-5060

  Taherkhani, Samira ^a,b   Mohammadi, Mahmood ^a   Daoud, Jamal ^b   Martel, Sylvain ^a   Tabrizian, Maryam ^b,c  

^a Institute of Biomedical Engineering   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

bioconjugation; biomicrocarrier; carbodiimide chemistry; magnetotactic bacteria; nanoliposome; self propelled targeted delivery

Indexed keywords

BIOCOMPATIBILITY; LIPOSOMES;

BIO-CONJUGATION; BIOMICROCARRIER; CARBODIIMIDE CHEMISTRY; MAGNETOTACTIC BACTERIA; NANOLIPOSOME; TARGETED DELIVERY;

BACTERIA;

ANTINEOPLASTIC AGENT; BIOMATERIAL; CYANAMIDE; DRUG CARRIER; LIPOSOME; NANOPARTICLE; PROTEIN BINDING;

3T3 CELL LINE; ALPHAPROTEOBACTERIA; ANIMAL; BACTERIUM; CELL SEPARATION; CHEMISTRY; CONFOCAL MICROSCOPY; DIFFUSION; DOSE RESPONSE; FLOW CYTOMETRY; GENE VECTOR; HUMAN; IC50; MAGNETISM; METABOLISM; MOUSE; NANOTECHNOLOGY; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

ALPHAPROTEOBACTERIA; ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIA; BIOCOMPATIBLE MATERIALS; CARBODIIMIDES; CELL LINE, TUMOR; CELL SEPARATION; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; INHIBITORY CONCENTRATION 50; LIPOSOMES; MAGNETICS; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; NIH 3T3 CELLS; PROTEIN BINDING;

EID: 84901649873     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn5011304     Document Type: Article

References (59)

1. Pouponneau, P.; Leroux, J. C.; Soulez, G.; Gaboury, L.; Martel, S. Co-Encapsulation of Magnetic Nanoparticles and Doxorubicin into Biodegradable Microcarriers for Deep Tissue Targeting by Vascular MRI Navigation Biomaterials 2011, 32, 3481-3486
2. Al-Jamal, W. T.; Kostarelos, K. Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1094-1104
3. Mikhaylov, G.; Mikac, U.; Magaeva, A. A.; Itin, V. I.; Naiden, E. P.; Psakhye, I.; Babes, L.; Reinheckel, T.; Peters, C.; Zeiser, R. et al. Ferri-Liposomes as an MRI-Visible Drug-Delivery System for Targeting Tumours and Their Microenvironment Nat. Nanotechnol. 2011, 6, 594-602
4. Torchilin, V. P. Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example. In Handbook of Experimental Pharmacology; Hofmann, F. B., Ed.; Springer: New York, 2010; pp 3-53.
5. Brannon-Peppas, L.; Blanchette, J. O. Nanoparticle and Targeted Systems for Cancer Therapy Adv. Drug Delivery Rev. 2012, 64, 206-212
6. Owens, D. E.; Peppas, N. A. Opsonization, Biodistribution, and Pharmacokinetics of Polymeric Nanoparticles Int. J. Pharm. 2006, 307, 93-102
7. Kaminskas, L. M.; McLeod, V. M.; Kelly, B. D.; Sberna, G.; Boyd, B. J.; Williamson, M.; Owen, D. J.; Porter, C. J. A Comparison of Changes to Doxorubicin Pharmacokinetics, Antitumor Activity, and Toxicity Mediated by PEGylated Dendrimer and PEGylated Liposome Drug Delivery Systems Nanomedicine 2012, 8, 103-111
8. Mitchell, N.; Kalber, T. L.; Cooper, M. S.; Sunassee, K.; Chalker, S. L.; Shaw, K. P.; Ordidge, K. L.; Badar, A.; Janes, S. M.; Blower, P. J. et al. Incorporation of Paramagnetic, Fluorescent and PET/SPECT Contrast Agents into Liposomes for Multimodal Imaging Biomaterials 2013, 34, 1179-1192
9. Torchilin, V. P. Recent Advances with Liposomes as Pharmaceutical Carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
10. Minchinton, A. I.; Tannock, I. F. Drug Penetration in Solid Tumours Nat. Rev. Cancer 2006, 6, 583-592
11. Heldin, C. H.; Rubin, K.; Pietras, K.; Ostman, A. High Interstitial Fluid Pressure-An Obstacle in Cancer Therapy Nat. Rev. Cancer 2004, 4, 806-813
12. Brown, J. M.; William, W. R. Exploiting Tumour Hypoxia in Cancer Treatment Nat. Rev. Cancer 2004, 4, 437-447
13. Harrison, L.; Blackwell, K. Hypoxia and Anemia: Factors in Decreased Sensitivity to Radiation Therapy and Chemotherapy? Oncologist 2004, 9, 31-40
14. Martel, S. Magnetic Therapeutic Delivery Using Navigable Agents Ther. Delivery 2014, 5, 189-204
15. Forbes, N. S. Engineering the Perfect (Bacterial) Cancer Therapy Nat. Rev. Cancer 2010, 10, 784-793
16. Ganai, S.; Arenas, R. B.; Sauer, J. P.; Bentley, B.; Forbes, N. S. In Tumors Salmonella Migrate Away from Vasculature toward the Transition Zone and Induce Apoptosis Cancer Gene Ther. 2011, 18, 457-466
17. Koumoutsakos, P.; Pivkin, I.; Milde, F. The Fluid Mechanics of Cancer and Its Therapy Annu. Rev. Fluid Mech. 2013, 45, 325-355
18. Felfoul, O.; Mathieu, J. B.; Martel, S. In A Comparative Study between MC-1 Cells and Magnetic Microparticles Used for Enhanced Target Delivery of Therapeutic Agents in the Microvasculature, 2 nd ed.; Biennial P IEEE Ras-Embs Int.: Scottsdale, AZ, 2008; pp 694-699.
19. Martel, S.; Mohammadi, M.; Felfoul, O.; Lu, Z.; Pouponneau, P. Flagellated Magnetotactic Bacteria as Controlled MRI-Trackable Propulsion and Steering Systems for Medical Nanorobots Operating in the Human Microvasculature Int. J. Rob. Res. 2009, 28, 571-582
20. Martel, S. Navigation Control of Micro-Agents in the Vascular Network: Challenges and Strategies for Endovascular Magnetic Navigation Control of Microscale Drug Delivery Carriers IEEE Control Syst. 2013, 33, 119-134
21. McDonald, D. M.; Baluk, P. Significance of Blood Vessel Leakiness in Cancer Cancer Res. 2002, 62, 5381-5385
22. Frankel, R. B.; Bazylinski, D. A.; Johnson, M. S.; Taylor, B. L. Magneto-Aerotaxis in Marine Coccoid Bacteria Biophys. J. 1997, 73, 994-1000
23. Faivre, D.; Schuler, D. Magnetotactic Bacteria and Magnetosomes Chem. Rev. 2008, 108, 4875-4898
24. Arakaki, A.; Nakazawa, H.; Nemoto, M.; Mori, T.; Matsunaga, T. Formation of Magnetite by Bacteria and Its Application J. R. Soc., Interface 2008, 5, 977-999
25. De Lanauze, D.; Felfoul, O.; Turcot, J. P.; Mohammadi, M.; Martel, S. Three-Dimensional Remote Aggregation and Steering of Magnetotactic Bacteria Microrobots for Drug Delivery Applications Int. J. Rob. Res. 2013, 1-16
26. Schulz, G. E. The Structure of Bacterial Outer Membrane Proteins Biochim. Biophys. Acta 2002, 1565, 308-317
27. Sun, J.; Li, Y.; Liang, X. J.; Wang, P. C. Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions J. Nanomater. 2011, 2011, 469031-469043
28. Kalia, J.; Raines, R. T. Advances in Bioconjugation Curr. Org. Chem. 2010, 14, 138-147
29. Hermanson, G. T. Bioconjugate Techniques, 2 nd ed.; Elsevier Academic Press: Amsterdam, Boston, 2008.
30. Stephan, M. T.; Moon, J. J.; Um, S. H.; Bershteyn, A.; Irvine, D. J. Therapeutic Cell Engineering with Surface-Conjugated Synthetic Nanoparticles Nat. Med. 2010, 16, 1035-1041
31. Berry, C. C. Progress in Functionalization of Magnetic Nanoparticles for Applications in Biomedicine J. Phys. D: Appl. Phys. 2009, 42, 1-9
32. Sun, C.; Lee, J. S. H.; Zhang, M. Q. Magnetic Nanoparticles in MR Imaging and Drug Delivery Adv. Drug Delivery Rev. 2008, 60, 1252-1265
33. Lang, C.; Schuler, D.; Faivre, D. Synthesis of Magnetite Nanoparticles for Bio- and Nanotechnology: Genetic Engineering and Biomimetics of Bacterial Magnetosomes Macromol. Biosci. 2007, 7, 144-151
34. Veiseh, O.; Gunn, J. W.; Zhang, M. Q. Design and Fabrication of Magnetic Nanoparticles for Targeted Drug Delivery and Imaging Adv. Drug Delivery Rev. 2010, 62, 284-304
35. Martel, S. Combining Pulsed and DC Gradients in a Clinical MRI-Based Microrobotic Platform to Guide Therapeutic Magnetic Agents in the Vascular Network Int. J. Adv. Rob. Syst. 2013, 10, 1-7
36. Klabunde, R. E. Cardiovascular Physiology Concepts, 2 nd ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2011.
37. Jiang, W.; Saxena, A.; Song, B.; Ward, B. B.; Beveridge, T. J.; Myneni, S. C. B. Elucidation of Functional Groups on Gram-Positive and Gram-Negative Bacterial Surfaces Using Infrared Spectroscopy Langmuir 2004, 20, 11433-11442
38. Silhavy, T. J.; Kahne, D.; Walker, S. The Bacterial Cell Envelope Cold Spring Harbor Perspect. Biol. 2010, 2, 1-26
39. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W.; Nie, S. In Vivo Cancer Targeting and Imaging with Semiconductor Quantum Dots Nat. Biotechnol. 2004, 22, 969-976
40. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 6315-6320
41. Meyer, R. L.; Zhou, X. F.; Tang, L. N.; Arpanaei, A.; Kingshott, P.; Besenbacher, F. Immobilisation of Living Bacteria for AFM Imaging under Physiological Conditions Ultramicroscopy 2010, 110, 1349-1357
42. Luo, Y. R. Comprehensive Handbook of Chemical Bond Energies; CRC Press, Taylor and Francis Group: Boca Raton, FL, 2007.
43. Garrett, H. R.; Grisham, C. M. Biochemistry, 5 th ed.; Brooks/Cole, Cengage Learning: Belmont, CA, 2012.
44. Huang, Y. F.; Wang, Y. F.; Yan, X. P. Amine-Functionalized Magnetic Nanoparticles for Rapid Capture and Removal of Bacterial Pathogens Environ. Sci. Technol. 2010, 44, 7908-7913
45. Marttila, A. T.; Laitinen, O. H.; Airenne, K. J.; Kulik, T.; Bayer, E. A.; Wilchek, M.; Kulomaa, M. S. Recombinant Neutralite Avidin: A Non-Glycosylated, Acidic Mutant of Chicken Avidin That Exhibits High Affinity for Biotin and Low Non-Specific Binding Properties FEBS Lett. 2000, 467, 31-36
46. Thorek, D. L. J.; Elias, D. R.; Tsourkas, A. Comparative Analysis of Nanoparticle-Antibody Conjugations: Carbodiimide versus Click Chemistry Mol. Imaging 2009, 8, 221-229
47. Danila, D.; Partha, R.; Elrod, D. B.; Lackey, M.; Casscells, S. W.; Conyers, J. L. Antibody-Labeled Liposomes for CT Imaging of Atherosclerotic Plaques: In Vitro Investigation of an Anti-ICAM Antibody-Labeled Liposome Containing Iohexol for Molecular Imaging of Atherosclerotic Plaques via Computed Tomography Tex. Heart Inst. J. 2009, 36, 393-403
48. Martin, R. B. Free Energies and Equilibria of Peptide Bond Hydrolysis and Formation Biopolymers 1998, 45, 351-353
49. Osaka, T.; Nakanishi, T.; Shanmugam, S.; Takahama, S.; Zhang, H. Effect of Surface Charge of Magnetite Nanoparticles on Their Internalization into Breast Cancer and Umbilical Vein Endothelial Cells Colloid Surf. B 2009, 71, 325-330
50. Marquez, M.; Nilsson, S.; Lennartsson, L.; Liu, Z. X.; Tammela, T.; Raitanen, M.; Holmberg, A. R. Charge-Dependent Targeting: Results in Six Tumor Cell Lines Anticancer Res. 2004, 24, 1347-1351
51. Miller, C. R.; Bondurant, B.; McLean, S. D.; McGovern, K. A.; O'Brien, D. F. Liposome-Cell Interactions in Vitro: Effect of Liposome Surface Charge on the Binding and Endocytosis of Conventional and Sterically Stabilized Liposomes Biochemistry 1998, 37, 12875-12883
52. Garcia-Perez, B. E.; De la Cruz-Lopez, J. J.; Castaneda-Sanchez, J. I.; Munoz-Duarte, A. R.; Hernandez-Perez, A. D.; Villegas-Castrejon, H.; Garcia-Latorre, E.; Caamal-Ley, A.; Luna-Herrera, J. Macropinocytosis Is Responsible for the Uptake of Pathogenic and Non-Pathogenic Mycobacteria by B Lymphocytes (Raji Cells) BMC Microbiol. 2012, 12, 1-14
53. Garcia-Perez, B. E.; Hernandez-Gonzalez, J. C.; Garcia-Nieto, S.; Luna-Herrera, J. Internalization of a Non-Pathogenic Mycobacteria by Macropinocytosis in Human Alveolar Epithelial A549 Cells Microb. Pathog. 2008, 45, 1-6
54. Andar, A. U.; Hood, R. R.; Vreeland, W. N.; Devoe, D. L.; Swaan, P. W. Microfluidic Preparation of Liposomes to Determine Particle Size Influence on Cellular Uptake Mechanisms Pharm. Res. 2013, 31, 401-413
55. Martina, M. S.; Nicolas, V.; Wilhelm, C.; Meenager, C.; Barratt, G.; Lesieur, S. The in Vitro Kinetics of the Interactions between PEG-ylated Magnetic-Fluid-Loaded Liposomes and Macrophages Biomaterials 2007, 28, 4143-4153
56. Hoskin, D. W.; Ramamoorthy, A. Studies on Anticancer Activities of Antimicrobial Peptides Biochim. Biophys. Acta 2008, 1778, 357-375
57. Immordino, M. L.; Dosio, F.; Cattel, L. Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential Int. J. Nanomed. 2006, 1, 297-315
58. Bazylinski, D. A.; Williams, T. J.; Lefevre, C. T.; Berg, R. J.; Zhang, C. L. L.; Bowser, S. S.; Dean, A. J.; Beveridge, T. J. Magnetococcus Marinus gen. nov., sp nov., a Marine, Magnetotactic Bacterium That Represents a Novel Lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the Base of the Alphaproteobacteria Int. J. Syst. Evol. Microbiol. 2013, 63, 801-808
59. Ngamwongsatit, P.; Banada, P. P.; Panbangred, W.; Bhunia, A. K. WST-1-Based Cell Cytotoxicity Assay as a Substitute for MTT-Based Assay for Rapid Detection of Toxigenic Bacillus Species Using Cho Cell Line J. Microbiol. Methods 2008, 73, 211-215